Join to access to all OVN content. Join for Free
All about Job Offers and what to be aware of
job offer negotiations compensation discussions employment agreements non-compete agreements sign-on bonuses

All about Job Offers and what to be aware of


Share This Article


Summary

E66 • Aug 17, 2021 • 41 mins

In this episode, Tom Caravela welcomes Anthony Greco to discuss job offer negotiations. Anthony shares insights on clear communication and understanding legal aspects during compensation discussions. They explore the risks of over-negotiation and emphasize early talks on compensation. The conversation covers negotiable elements like sign-on bonuses and long-term incentives. Anthony offers guidance on navigating non-compete and non-solicitation agreements, providing legal advice and identifying red flags in employment agreements. The episode concludes with reflections on the candidate's experience during the hiring process.

Anthony Greco, Talent Acquisition Lead at BMS discusses what you need to know about job offers and how to properly handle them.

Anthony shares….

👉 What should be included in an Offer Letter

👉 How to best negotiate a Job Offer

👉 Is it true to “Never Accept the First Offer”?

👉 How do sign on bonuses work and when can you expect one

👉 What does “At Will Employment” mean

👉 How to handle a “non compete” and why it differs from a “non solicitation”

Click for Source
job offer negotiations, compensation discussions, employment agreements, non-compete agreements, sign-on bonuses

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
COMP: How HR Determines Compensation and Titles for Job Offers
Partner Avatar MSL Talk: Tom Caravela, Chris Castin

COMP: How HR Determines Compensation and Titles for Job Offers

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Explore OVN